EPISODE · Jun 4, 2021 · 30 MIN
Amicus Therapeutics CEO John Crowley
from Talks at GS · host Goldman Sachs
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic. Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Amicus Therapeutics CEO John Crowley
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m